<DOC>
	<DOCNO>NCT02292615</DOCNO>
	<brief_summary>In prospective cohort study , patient newly diagnose gynecologic cancer ( include cervical , endometrial , ovarian cancer ) patient suspicious recurrent gynecologic cancer enrol . The study period two year estimate patient number 220 . Patients undergo image study treatment . The diagnostic accuracy MR-PET cancer stag potential image biomarkers monitor treatment response predict treatment outcome investigate .</brief_summary>
	<brief_title>Application Integrated MR-PET Patients With Gynecologic Cancers</brief_title>
	<detailed_description />
	<criteria>1 . Group 1 : Patients newly diagnose gynecologic cancer ( include cervical , endometrial , ovarian cancer ) . 2 . Group 2 : Patients suspicious recurrent gynecologic cancer ( include cervical , endometrial , ovarian cancer ) . 3 . Group 3 : Patients ovarian cancer debulking surgery go receive adjuvant chemotherapy . 1 . Age &lt; 20 &gt; 90 year old 2 . Contraindication MRI : 3 . Contraindication MR contrast medium ( Cre &gt; 2.0 ) 4 . History malignancy 5 . Prior arthroplasty hip pelvic bone surgery metallic fixation ( may cause artifact MRI ) 6 . Pregnant lactating woman</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>